PRPS1
Ribose-phosphate pyrophosphokinase 1
Also known as: CMTX5, DFN2, DFNX1, PPRibP, PRPS1_HUMAN, PRS-I
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60891
- Gene
- PRPS1
- Ensembl
- ENSG00000147224
- Chromosome
- X
- Canonical length
- 318 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an enzyme that catalyzes the phosphoribosylation of ribose 5-phosphate to 5-phosphoribosyl-1-pyrophosphate, which is necessary for purine metabolism and nucleotide biosynthesis. Defects in this gene are a cause of phosphoribosylpyrophosphate synthetase superactivity, Charcot-Marie-Tooth disease X-linked recessive type 5 and Arts Syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
318 residues, UniProt reviewed canonical sequence.
>P60891|PRPS1
1 MPNIKIFSGS SHQDLSQKIA DRLGLELGKV VTKKFSNQET CVEIGESVRG EDVYIVQSGC
61 GEINDNLMEL LIMINACKIA SASRVTAVIP CFPYARQDKK DKSRAPISAK LVANMLSVAG
121 ADHIITMDLH ASQIQGFFDI PVDNLYAEPA VLKWIRENIS EWRNCTIVSP DAGGAKRVTS
181 IADRLNVDFA LIHKERKKAN EVDRMVLVGD VKDRVAILVD DMADTCGTIC HAADKLLSAG
241 ATRVYAILTH GIFSGPAISR INNACFEAVV VTNTIPQEDK MKHCSKIQVI DISMILAEAI
301 RRTHNGESVS YLFSHVPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRPS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 94 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 94 nTPM
- bone marrow: 55 nTPM
- skeletal muscle: 51 nTPM
- hypothalamus: 50 nTPM
- thymus: 48 nTPM
- liver: 48 nTPM
Single-cell type
- erythrocyte progenitors: 75 nCPM
- epicardial cells: 71 nCPM
- hepatocytes: 67 nCPM
- oocytes: 55 nCPM
- hofbauer cells: 54 nCPM
- adrenal medulla cells: 53 nCPM
Immune cell
- naive CD4 T-cell: 36 nTPM
- T-reg: 36 nTPM
- memory CD8 T-cell: 32 nTPM
- memory CD4 T-cell: 32 nTPM
- naive B-cell: 31 nTPM
- MAIT T-cell: 31 nTPM
Brain region
- choroid plexus: 92 nTPM
- hypothalamus: 50 nTPM
- midbrain: 50 nTPM
- pons: 46 nTPM
- medulla oblongata: 42 nTPM
- white matter: 39 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRPS1.
Disease | AllUniProt
Conditions PRPS1 is implicated in, by any mechanism.
- Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) MIM:300661
- Charcot-Marie-Tooth disease, X-linked recessive, 5 (CMTX5) MIM:311070
- ARTS syndrome (ARTS) MIM:301835
- Deafness, X-linked, 1 (DFNX1) MIM:304500
Disease | GeneticClinVar
44 pathogenic / likely-pathogenic of 429 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Phosphoribosylpyrophosphate synthetase superactivity
- Charcot-Marie-Tooth Neuropathy X
- Hearing loss, X-linked 1
- Arts syndrome
- Charcot-Marie-Tooth disease X-linked recessive 5
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 3.73
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 5-phosphoribose 1-diphosphate biosynthetic process
- nervous system development
- purine nucleobase metabolic process
- purine nucleotide biosynthetic process
- pyrimidine nucleotide biosynthetic process
- ribonucleoside monophosphate biosynthetic process
- urate biosynthetic process
- hypoxanthine biosynthetic process
Molecular functions
- ATP binding
- identical protein binding
- kinase activity
- magnesium ion binding
- protein homodimerization activity
- ribose phosphate diphosphokinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphoribosyltransferase domain
- Phosphoribosyl pyrophosphate synthetase, conserved site
- Ribose-phosphate pyrophosphokinase
- Phosphoribosyltransferase-like
- Ribose-phosphate pyrophosphokinase, N-terminal domain
- Ribose-phosphate pyrophosphokinase, bacterial-type
- N-terminal domain of ribose phosphate pyrophosphokinase
- Phosphoribosyl synthetase-associated domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRPS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRPS1 as an antibody target. Whether an autoantibody or antibody against PRPS1 could matter depends on whether native PRPS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRPS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRPS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...